Comment on "Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort".
作者信息
Meng Yufan, Fan Zhiyao, Yang Jian, Li Yongzheng, Zhan Hanxiang
机构信息
From the Division of Pancreatic Surgery, Department of General Surgery, Qilu Hospital, Shandong University, Jinan, Shandong Province, China.
出版信息
Ann Surg Open. 2023 Mar 14;4(1):e266. doi: 10.1097/AS9.0000000000000266. eCollection 2023 Mar.
Abstract
摘要
相似文献
1
Comment on "Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort".关于“大型多中心队列中直径<3 cm的无功能性胰腺神经内分泌肿瘤患者的保留实质和肿瘤切除的长期结局”的评论
Ann Surg Open. 2023 Mar 14;4(1):e266. doi: 10.1097/AS9.0000000000000266. eCollection 2023 Mar.
2
Response to Commentary on '"Long-Term Outcomes of Parenchyma-Sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort".对《“大型多中心队列中直径<3 cm的无功能性胰腺神经内分泌肿瘤患者的实质保留与肿瘤切除的长期结局”》评论的回应
Ann Surg Open. 2023 Apr 17;4(2):e277. doi: 10.1097/AS9.0000000000000277. eCollection 2023 Jun.
3
Comment on: Are Parenchyma-Sparing Resections Really Appropriate for Small (<3 cm) Nonfunctional Pancreatic Neuroendocrine Tumors?关于《保留实质的切除术真的适用于小（<3 cm）无功能胰腺神经内分泌肿瘤吗？》的评论
Ann Surg Open. 2023 Jan 30;4(1):e249. doi: 10.1097/AS9.0000000000000249. eCollection 2023 Mar.
4
Risk of malignancy and prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors.散发性切除的小（≤2厘米）无功能胰腺神经内分泌肿瘤的恶性风险及预后
Gland Surg. 2021 Jan;10(1):219-232. doi: 10.21037/gs-20-582.
5
[Long-term results after parenchyma-sparing vs. oncologic resection of nonfunctional pancreatic neuroendocrine neoplasms < 3 cm].[小于3厘米的无功能性胰腺神经内分泌肿瘤保留实质与肿瘤切除术后的长期结果]
Chirurgie (Heidelb). 2023 Apr;94(4):365-366. doi: 10.1007/s00104-023-01843-8. Epub 2023 Feb 27.
6
Comparison of Oncological and Surgical Outcomes Between Formal Pancreatic Resections and Parenchyma-Sparing Resections for Small PanNETs (<2 cm): Pancreas2000 Research and Educational Program (Course 9) Study Protocol.小胰腺神经内分泌肿瘤（<2 cm）的标准胰腺切除术与保留实质切除术的肿瘤学和手术结果比较：Pancreas2000研究与教育项目（课程9）研究方案。
Front Med (Lausanne). 2020 Sep 10;7:559. doi: 10.3389/fmed.2020.00559. eCollection 2020.
7
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review.胰腺神经内分泌肿瘤的保守治疗和保留实质的切除术：文献回顾。
Int J Surg. 2015 Sep;21 Suppl 1:S10-4. doi: 10.1016/j.ijsu.2015.04.089. Epub 2015 Jun 26.
8
Sporadic nonfunctional pancreatic neuroendocrine tumors: Risk of lymph node metastases and aggressiveness according to tumor size: A multicenter international study.散发性无功能性胰腺神经内分泌肿瘤：根据肿瘤大小判断淋巴结转移风险和侵袭性：一项多中心国际研究。
Surgery. 2022 Sep;172(3):975-981. doi: 10.1016/j.surg.2022.04.013. Epub 2022 May 24.
9
Response to Commentary "Are Parenchyma-Sparing Resections Really Appropriate for Small (<3 cm) Non-Functional Pancreatic Neuroendocrine Tumors?".对评论文章《保留实质的切除术真的适用于小（<3厘米）无功能胰腺神经内分泌肿瘤吗？》的回应
Ann Surg Open. 2023 Feb 20;4(1):e245. doi: 10.1097/AS9.0000000000000245. eCollection 2023 Mar.
10
Parenchyma-sparing resections for pancreatic neoplasms.胰腺肿瘤的保留胰腺实质切除术。
J Hepatobiliary Pancreat Sci. 2010 Nov;17(6):782-7. doi: 10.1007/s00534-009-0224-1. Epub 2009 Oct 29.
本文引用的文献
1
Long-term Outcomes of Parenchyma-sparing and Oncologic Resections in Patients With Nonfunctional Pancreatic Neuroendocrine Tumors <3 cm in a Large Multicenter Cohort.在大型多中心队列中，对于<3cm 的无功能性胰腺神经内分泌肿瘤患者，行保留实质和肿瘤切除的长期结果。
Ann Surg. 2022 Sep 1;276(3):522-531. doi: 10.1097/SLA.0000000000005559. Epub 2022 Jun 27.
2
The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors.北美神经内分泌肿瘤学会关于胰腺神经内分泌肿瘤手术治疗的共识文件。
Pancreas. 2020 Jan;49(1):1-33. doi: 10.1097/MPA.0000000000001454.
3
Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.非转移性胰腺神经内分泌肿瘤淋巴结清扫术的结果：国家癌症数据库的倾向评分加权分析。
Ann Surg Oncol. 2019 Sep;26(9):2722-2729. doi: 10.1245/s10434-019-07506-5. Epub 2019 Jun 17.
4
Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.定义胰腺神经内分泌肿瘤淋巴结清扫术的作用：美国神经内分泌肿瘤研究组对 695 例患者的 8 个机构研究。
Ann Surg Oncol. 2019 Aug;26(8):2517-2524. doi: 10.1245/s10434-019-07367-y. Epub 2019 Apr 19.
5
Management of asymptomatic, well-differentiated PNETs: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association.无症状、分化良好的 PNETs 的管理：美洲肝胆胰协会德尔菲共识过程的结果。
HPB (Oxford). 2019 May;21(5):515-523. doi: 10.1016/j.hpb.2018.09.020. Epub 2018 Dec 5.
6
A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms.胰腺神经内分泌肿瘤预后因素的 Meta 分析。
Sci Rep. 2018 May 8;8(1):7271. doi: 10.1038/s41598-018-24072-0.
7
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.《欧洲神经内分泌肿瘤学会功能性胰腺神经内分泌肿瘤和非功能性胰腺神经内分泌肿瘤患者管理共识指南更新》
Neuroendocrinology. 2016;103(2):153-71. doi: 10.1159/000443171. Epub 2016 Jan 5.
8
Postoperative Outcomes of Enucleation and Standard Resections in Patients with a Pancreatic Neuroendocrine Tumor.胰腺神经内分泌肿瘤患者眼球摘除术和标准切除术的术后结果
World J Surg. 2016 Mar;40(3):715-28. doi: 10.1007/s00268-015-3341-9.
9
NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.NANETS 治疗指南：胃和胰腺神经内分泌肿瘤的良好分化型。
Pancreas. 2010 Aug;39(6):735-52. doi: 10.1097/MPA.0b013e3181ebb168.
Zotero 插件